HSA-2023-0032-V432

Minor variation for application HSA-2023-0032. Minor variation: New Dosage Strength for Respiralimab — major revision

Variation Number
HSA-2023-0032-V432
Type
Minor
Application
HSA-2023-0032
Change
CHG-2021-0132
Status
Active
Fee
€1,111
Submitted
—
Approved
—
Description

Minor variation: New Dosage Strength for Respiralimab — major revision